Published in Cell Stress Chaperones on March 05, 2008
Determination of inflammatory and prominent proteomic changes in plasma and adipose tissue after high-intensity intermittent training in overweight and obese males. J Appl Physiol (1985) (2012) 0.98
The response of interleukin-6 and soluble interleukin-6 receptor isoforms following intermittent high intensity and continuous moderate intensity cycling. Cell Stress Chaperones (2010) 0.97
The reliability of the IL-6, sIL-6R and sgp130 response to a preloaded time trial. Eur J Appl Physiol (2010) 0.79
IL-6 Transsignaling in Patients with Chronic Spontaneous Urticaria. PLoS One (2015) 0.79
The detection and measurement of interleukin-6 in venous and capillary blood samples, and in sweat collected at rest and during exercise. Eur J Appl Physiol (2014) 0.77
Effect of phlebodium decumanum on the immune response induced by training in sedentary university students. J Sports Sci Med (2011) 0.75
An evaluation of low volume high-intensity intermittent training (HIIT) for health risk reduction in overweight and obese men. BMC Obes (2017) 0.75
Heat stress, gastrointestinal permeability and interleukin-6 signaling - Implications for exercise performance and fatigue. Temperature (Austin) (2016) 0.75
Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J (2003) 10.77
Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell (1990) 5.06
Directing transition from innate to acquired immunity: defining a role for IL-6. J Immunol (2005) 3.17
Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase. Diabetes (2006) 2.80
The soluble interleukin 6 receptor: mechanisms of production and implications in disease. FASEB J (2001) 2.78
Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy. Blood (2000) 2.31
Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses. Eur J Biochem (2001) 2.30
IL-6 transsignaling: the in vivo consequences. J Interferon Cytokine Res (2005) 2.17
Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J Clin Endocrinol Metab (2002) 1.98
Interleukin-6 trans-signalling in chronic inflammation and cancer. Scand J Immunol (2006) 1.95
Structure of an extracellular gp130 cytokine receptor signaling complex. Science (2001) 1.94
Interleukin-6 is a novel factor mediating glucose homeostasis during skeletal muscle contraction. Diabetes (2004) 1.73
Acute effects of recombinant human interleukin-6 on endocrine and central nervous sleep functions in healthy men. J Clin Endocrinol Metab (1998) 1.70
Improved detection of lactate threshold during exercise using a log-log transformation. J Appl Physiol (1985) (1985) 1.66
A trauma-like elevation of plasma cytokines in humans in response to treadmill running. J Physiol (1998) 1.59
The role of soluble receptors in cytokine biology: the agonistic properties of the sIL-6R/IL-6 complex. Biochim Biophys Acta (2002) 1.53
Immunologic mediators as parameters of the reaction to strenuous exercise. Int J Sports Med (1991) 1.50
Interleukin-6-mediated hyperalgesia/allodynia and increased spinal IL-6 expression in a rat mononeuropathy model. J Interferon Cytokine Res (1996) 1.48
The metabolic role of IL-6 produced during exercise: is IL-6 an exercise factor? Proc Nutr Soc (2004) 1.45
Effects of hypocaloric diet and exercise training on inflammation and adipocyte lipolysis in obese postmenopausal women. J Clin Endocrinol Metab (2004) 1.40
Acute IL-6 treatment increases fatty acid turnover in elderly humans in vivo and in tissue culture in vitro. Am J Physiol Endocrinol Metab (2004) 1.40
Retracted Interleukin-6 receptor expression in contracting human skeletal muscle: regulating role of IL-6. FASEB J (2005) 1.39
Physical training modulates proinflammatory cytokines and the soluble Fas/soluble Fas ligand system in patients with chronic heart failure. J Am Coll Cardiol (2002) 1.31
Physiological roles of muscle-derived interleukin-6 in response to exercise. Curr Opin Clin Nutr Metab Care (2007) 1.23
Changes in inflammatory biomarkers following one-year of moderate resistance training in overweight women. Int J Obes (Lond) (2007) 1.16
Effect of exercise, training, and glycogen availability on IL-6 receptor expression in human skeletal muscle. J Appl Physiol (1985) (2005) 1.12
Shedding of the soluble IL-6 receptor is triggered by Ca2+ mobilization, while basal release is predominantly the product of differential mRNA splicing in THP-1 cells. Eur J Immunol (1998) 1.07
The influence of exercise-induced plasma volume changes on the interpretation of biochemical parameters used for monitoring exercise, training and sport. Sports Med (1998) 1.03
Sleep enhances IL-6 trans-signaling in humans. FASEB J (2006) 1.03
A five year physiological case study of an Olympic runner. Br J Sports Med (1998) 0.95
IL-6 increases muscle insulin sensitivity only at superphysiological levels. Am J Physiol Endocrinol Metab (2007) 0.93
Cloning and expression of an alternatively spliced mRNA encoding a soluble form of the human interleukin-6 signal transducer gp130. FEBS Lett (1997) 0.93
Human resting extracellular heat shock protein 72 concentration decreases during the initial adaptation to exercise in a hot, humid environment. Cell Stress Chaperones (2006) 0.92
Acute interleukin-6 administration impairs athletic performance in healthy, trained male runners. Can J Appl Physiol (2004) 0.92
The effects of exercise on perceived stress and IL-6 levels among older adults. Biol Res Nurs (2007) 0.88
Recombinant human interleukin-6 infusion during low-intensity exercise does not enhance whole body lipolysis or fat oxidation in humans. Am J Physiol Endocrinol Metab (2005) 0.82
Effects of repeated stress on expression of interleukin-6 (IL-6) and IL-6 receptor mRNAs in rat hypothalamus and midbrain. Life Sci (2000) 0.81
Development of a monoclonal antibody-based enzyme-linked immunoabsorbent assay for the binding of gp130 to the IL-6/IL-6R complex and its competitive inhibition. J Immunol Methods (2004) 0.78
Fat oxidation after acipimox-induced reduction in plasma nonesterified fatty acids during exercise at 0 degrees C and 20 degrees C. Metabolism (2004) 0.78
Systematic genetic analysis with ordered arrays of yeast deletion mutants. Science (2001) 24.48
Whole-genome association study of bipolar disorder. Mol Psychiatry (2008) 6.80
Codon usage can affect efficiency of translation of genes in Escherichia coli. Nucleic Acids Res (1984) 4.51
Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med (2001) 4.27
Is your 'double-blind' design truly double-blind? Br J Psychiatry (1989) 3.98
Phosphorylation of the MAP kinase ERK2 promotes its homodimerization and nuclear translocation. Cell (1998) 3.80
5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology (1987) 3.35
Coping with winter bed crises. New surveillance systems might help. BMJ (1999) 2.78
Nizatidine versus placebo in gastroesophageal reflux disease: a 12-week, multicenter, randomized, double-blind study. Am J Gastroenterol (1991) 2.54
THE RENAL CLEARANCE OF PENICILLINS F, G, K, AND X IN RABBITS AND MAN. J Clin Invest (1947) 2.29
The Leeds University Maternity Audit Project. Int J Qual Health Care (2002) 2.19
Associations of objectively measured sedentary behaviour and physical activity with markers of cardiometabolic health. Diabetologia (2013) 2.19
Nizatidine versus placebo in gastro-oesophageal reflux disease: a 12-week, multicentre, randomised, double-blind study. Br J Clin Pract Suppl (1994) 2.09
Carcinogenic effects of acrylamide in Sencar and A/J mice. Cancer Res (1984) 2.07
ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour properties. Gene Ther (2003) 2.05
Multicentre survey of radiologically inserted gastrostomy feeding tube (RIG) in the UK. Clin Radiol (2012) 2.04
'But they don't see the whole child...' health visitors may not welcome systematic reviews of child health surveillance. Br J Gen Pract (1999) 2.02
Single pass sequencing and physical and genetic mapping of human brain cDNAs. Nat Genet (1992) 2.01
Maintenance chemotherapy for anaplastic small cell carcinoma of the bronchus: a randomised, controlled trial. Cancer Chemother Pharmacol (1986) 1.87
Homograft replacement of the aortic valve. Immediate results and follow-up. Lancet (1968) 1.85
Non-invasive evaluation of liver cirrhosis using ultrasound. Clin Radiol (2009) 1.82
Dental caries and microbial acid production in twins. Caries Res (2005) 1.73
A comparison of the national registry of myocardial infarction 2 with the cooperative cardiovascular project. J Am Coll Cardiol (1999) 1.71
Ki-ras mutations in adenomas: a characteristic of cancer-bearing colorectal mucosa. J Pathol (1996) 1.70
Head and neck sarcomas: prognostic factors and implications for treatment. Br J Cancer (1993) 1.67
Relationships between B-lineage lymphocytes and stromal cells in long-term bone marrow cultures. Eur J Immunol (1987) 1.64
High-throughput profiling of the mitochondrial proteome using affinity fractionation and automation. Electrophoresis (2000) 1.61
The accuracy of diagnoses as reported in families with cancer: a retrospective study. J Med Genet (1999) 1.61
Mesalamine capsules for treatment of active ulcerative colitis: results of a controlled trial. Pentasa Study Group. Am J Gastroenterol (1993) 1.61
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Autopsy consent practice at US teaching hospitals: results of a national survey. Arch Intern Med (2000) 1.54
Sensitivity and selectivity in protein similarity searches: a comparison of Smith-Waterman in hardware to BLAST and FASTA. Genomics (1996) 1.53
Hydrated silicate minerals on Mars observed by the Mars Reconnaissance Orbiter CRISM instrument. Nature (2008) 1.52
Glycemic control and implant stabilization in type 2 diabetes mellitus. J Dent Res (2009) 1.50
Therapeutic potential of the LHRH agonist, ICI 118630, in the treatment of advanced prostatic carcinoma. Lancet (1983) 1.47
DISC1 association, heterogeneity and interplay in schizophrenia and bipolar disorder. Mol Psychiatry (2008) 1.47
The medium chain triglyceride diet and intractable epilepsy. Arch Dis Child (1986) 1.45
Variations in regional sweat composition in normal human males. Exp Physiol (2000) 1.45
Neurobiology of depression: an integrated view of key findings. Int J Clin Pract (2007) 1.44
Mucociliary clearance in patients with cystic fibrosis and in normal subjects. Am J Respir Crit Care Med (1994) 1.44
Consideration of spatial orientation mechanisms as related to elderly fallers. Gerontology (1989) 1.43
Distinct 3p21.3 deletions in lung cancer and identification of a new human semaphorin. Oncogene (1996) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
The landing of the NEAR-Shoemaker spacecraft on asteroid 433 Eros. Nature (2001) 1.41
Oesophageal pH has a power-law distribution in control and gastro-oesophageal reflux disease subjects. Aliment Pharmacol Ther (2004) 1.41
CT evaluation for 'quiescent' herniation following closure of diverting loop ileostomy. Colorectal Dis (2012) 1.41
Long-term management of Crohn's disease with mesalamine capsules (Pentasa). Pentasa Crohn's Disease Compassionate Use Study Group. Am J Gastroenterol (1993) 1.40
Chromosome 3p14 homozygous deletions and sequence analysis of FRA3B. Hum Mol Genet (1997) 1.39
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Food for New Zealanders. N Z Med J (1993) 1.39
KIM185, a monoclonal antibody to CD18 which induces a change in the conformation of CD18 and promotes both LFA-1- and CR3-dependent adhesion. Eur J Immunol (1993) 1.38
Genomic organization and partial duplication of the human alpha7 neuronal nicotinic acetylcholine receptor gene (CHRNA7). Genomics (1998) 1.36
Prophylactic chemotherapy of superficial transitional cell bladder carcinoma: an EORTC randomized trial comparing thiotepa, an epipodophyllotoxin (VM26) and TUR alone. Eur Urol (1982) 1.35
Evaluation of mutagenic and carcinogenic properties of brominated and chlorinated acetonitriles: by-products of chlorination. Fundam Appl Toxicol (1985) 1.34
Short chain fatty acid rectal irrigation for left-sided ulcerative colitis: a randomised, placebo controlled trial. Gut (1997) 1.32
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Understanding triclabendazole resistance. Exp Mol Pathol (2007) 1.28
Protein interactions in the herpes simplex virus type 1 VP16-induced complex: VP16 peptide inhibition and mutational analysis of host cell factor requirements. J Virol (1997) 1.27
Prevalence of gastroesophageal reflux in elderly patients in a primary care setting. Am J Gastroenterol (1991) 1.27
Occurrence of reiterated DNA sequences in strains of Streptomyces produced by an interspecific protoplast fusion. Mol Gen Genet (1981) 1.27
The ETO portion of acute myeloid leukemia t(8;21) fusion transcript encodes a highly evolutionarily conserved, putative transcription factor. Cancer Res (1994) 1.25
A perspex grid for localization of non-palpable mammographic lesions in breast biopsies. Histopathology (1989) 1.23
Ultrastructural injury of arterial endothelium. II. Effects of vasoactive amines. Arch Pathol (1969) 1.21
Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis. Pentasa UC Maintenance Study Group. Dig Dis Sci (1995) 1.20
Cytoplasmic tails of beta 1, beta 2, and beta 7 integrins differentially regulate LFA-1 function in K562 cells. Mol Biol Cell (1997) 1.19
Medicaid coverage of abortions in New York City: costs and benefits. Fam Plann Perspect (1974) 1.19
Budesonide enema for the treatment of active, distal ulcerative colitis and proctitis: a dose-ranging study. U.S. Budesonide enema study group. Gastroenterology (1998) 1.18
Effectiveness of pharmacotherapy for body dysmorphic disorder: a chart-review study. J Clin Psychiatry (2001) 1.18
Use of biological assay systems to assess the relative carcinogenic hazards of disinfection by-products. Environ Health Perspect (1982) 1.17
Margin of safety for discharge after apnea in preterm infants. Pediatrics (1997) 1.16
Psyllium is superior to docusate sodium for treatment of chronic constipation. Aliment Pharmacol Ther (1998) 1.14
Prognostic factors in superficial bladder tumors. A study of the European Organization for Research on Treatment of Cancer: Genitourinary Tract Cancer Cooperative Group. J Urol (1983) 1.11
Do urine dipsticks reliably predict microhematuria? The bloody truth! Ann Emerg Med (1988) 1.11
A comparison of silver stain and SYPRO Ruby Protein Gel Stain with respect to protein detection in two-dimensional gels and identification by peptide mass profiling. Electrophoresis (2000) 1.11
Thirteen-year follow-up of children and adolescents with chronic fatigue syndrome. Pediatrics (2001) 1.11
Validation of a novel diagnostic standard in HPV-positive oropharyngeal squamous cell carcinoma. Br J Cancer (2013) 1.10
ETO and AML1 phosphoproteins are expressed in CD34+ hematopoietic progenitors: implications for t(8;21) leukemogenesis and monitoring residual disease. Blood (1996) 1.09
Cardiovascular magnetic resonance imaging for non-invasive assessment of vascular function: validation against ultrasound. J Cardiovasc Magn Reson (2006) 1.08
Australian snowboard injury data base study. A four-year prospective study. Am J Sports Med (1993) 1.07
Further investigation of a chromosome 15 locus in schizophrenia: analysis of affected sibpairs from the NIMH Genetics Initiative. Am J Med Genet (1998) 1.07
Respiratory impairment induced by smoking in children in secondary schools. Br Med J (Clin Res Ed) (1984) 1.06
p53, c-erbB-2 and the epidermal growth factor receptor in the benign and malignant prostate. J Urol (1992) 1.06
Esophageal hypersensitivity may be a major cause of heartburn. Am J Gastroenterol (1999) 1.05
P53 and Ki-67 immunoreactivity in human prostate cancer and benign hyperplasia. Br J Urol (1992) 1.05
Preliminary evaluation of safety and activity of recombinant human interleukin 11 in patients with active Crohn's disease. Gastroenterology (1999) 1.05
Search for a light Higgs boson decaying to long-lived weakly interacting particles in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.05
Carcinogenicity of chloroform in drinking water to male Osborne-Mendel rats and female B6C3F1 mice. Fundam Appl Toxicol (1985) 1.04
Iris involvement in primary intraocular lymphoma: report of two cases and review of the literature. Surv Ophthalmol (2000) 1.03
A novel gamma subunit of the GABAA receptor identified using the polymerase chain reaction. FEBS Lett (1991) 1.03
Immature CD45RA(low)RO(low) T cells in the human cord blood. I. Antecedents of CD45RA+ unprimed T cells. J Immunol (1994) 1.02
The pattern of nocturnal and diurnal esophageal acid exposure in the pathogenesis of erosive mucosal damage. Am J Gastroenterol (1994) 1.01
From toxicological problem to therapeutic use: the discovery of the mode of action of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione (NTBC), its toxicology and development as a drug. J Inherit Metab Dis (1998) 1.00
Total androgen ablation: European experience. The EORTC GU Group. Urol Clin North Am (1991) 1.00
Transluminal iliac artery dilatation. Nonsurgical catheter treatment of atheromatous narrowing. JAMA (1974) 0.98
Neonatal malnutrition: an underlying etiology of necrotizing enterocolitis. Curr Surg (1983) 0.97
Long-term use of mesalamine (Rowasa) suppositories in remission maintenance of ulcerative proctitis. Am J Gastroenterol (2000) 0.97
Ultrastructural injury of arterial endothelium. 3. Effects of enzymes and surfactants. Arch Pathol (1969) 0.97
Long-term psychiatric patients in the community. Br J Psychiatry (1986) 0.97
Prognostic significance of failure to cross esophageal tumors by endoluminal ultrasound. Dis Esophagus (2008) 0.96
Thiabendazole in the treatment of lungworms in sheep. Aust Vet J (1966) 0.96